Jersey City Medical Center, Jersey City, New Jersey.
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Am J Cardiol. 2020 Aug 1;128:147-150. doi: 10.1016/j.amjcard.2020.04.054. Epub 2020 May 16.
Coronavirus disease 2019 (COVID-19) has become a global pandemic. It is still uncontrolled in most countries and no therapies are currently available. Various drugs are under investigation for its treatment. The disease is known to have worse outcomes in patients who have underlying cardiovascular disease. Chloroquine/hydroxychloroquine, azithromycin, remdesivir and lopinavir/ritonavir are currently being studied in trials and show some promise. Conduction disorders, heart failure, and mortality have been reported with the use of these drugs. It is important to have knowledge of potential cardiotoxic effects of these drugs before using them for COVID-19 patients for better allocation of healthcare resources and improvement in clinical outcomes.
2019 年冠状病毒病（COVID-19）已成为全球性大流行疾病。在大多数国家仍未得到控制，目前尚无特效疗法。目前正在研究各种药物来治疗该病。已知患有心血管疾病等基础疾病的患者预后更差。氯喹/羟氯喹、阿奇霉素、瑞德西韦和洛匹那韦/利托那韦目前正在临床试验中，显示出一定的前景。这些药物的使用与传导障碍、心力衰竭和死亡率有关。在将这些药物用于 COVID-19 患者之前，了解这些药物的潜在心脏毒性作用非常重要，这有助于更好地分配医疗资源和改善临床结果。
